6.2625

1.38% -0.0875

After Hours: 6.50 0.2375 +3.79%

Bioharvest Sciences Inc (BHST)

Overview News Price History Discussions Forecast

Bioharvest Sciences Inc stock is traded at $6.2625, with a volume of 8,890. It is down -1.38% in the last 24 hours and down -2.98% over the past month. BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Previous Close:

$6.35

Open:

$6.2826

24h Volume:

8,890

Relative Volume:

0.39

Market Cap:

$108.53M

Revenue:

$22.43M

Net Income/Loss:

$-17.19M

P/E Ratio:

-4.7129

EPS:

-1.3288

Net Cash Flow:

$-10.02M

1W Performance:

-0.48%

1M Performance:

-2.98%

6M Performance:

+1.83%

1Y Performance:

+0.00%

1-Day Range:

$6.25

$6.35

1-Week Range:

$6.25

$6.43

52-Week Range:

$4.7237

$6.99

Bioharvest Sciences Inc Stock (BHST) Company Profile

Name

Bioharvest Sciences Inc

Sector

Consumer Defensive (249)

Industry

Packaged Foods (72)

Phone

Address

Employee

Twitter

Next Earnings Date

Latest SEC Filings

BHST's Discussions on Twitter

Compare BHST with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BHST Bioharvest Sciences Inc	6.2625	109.04M	22.43M	-17.19M	-10.02M	-1.3288
KHC Kraft Heinz Co	26.73	31.13B	25.43B	2.66B	3.03B	2.19
GIS General Mills Inc	54.26	29.23B	19.64B	2.56B	2.48B	4.55
K Kellanova	82.63	28.58B	12.63B	1.38B	863.00M	3.96
MKC Mccormick Co Inc	72.73	19.07B	6.68B	792.60M	774.40M	2.94
HRL Hormel Foods Corp	30.68	16.19B	11.91B	756.75M	890.57M	1.37

Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-05-25	Initiated	Craig Hallum	Buy
Dec-18-24	Initiated	Maxim Group	Buy

Bioharvest Sciences Inc Stock (BHST) Latest News

May 24, 2025

BioHarvest Sciences CEO discusses entrance into fragrance industryICYMI - Proactive Investors

May 24, 2025

May 22, 2025

CDMO Company Expands into the Fragrance Market - Beauty Packaging

May 22, 2025

HC Wainwright Issues Pessimistic Estimate for BHST Earnings - Defense World

May 22, 2025

May 21, 2025

BioHarvest enters fragrance market with new AI-assisted project By Investing.com - Investing.com South Africa

May 21, 2025

BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound - marketscreener.com

May 21, 2025

BioHarvest Sciences signs contract to develop plant-based fragrance via Botanical Synthesis - Proactive financial news

May 21, 2025

Small cap wrap: Delivra Health, BioHarvest, U.S. Global Investors, Midnight Sun Mining... - Proactive financial news

May 21, 2025

BioHarvest Secures New CDMO Contract to Develop Plant-based Frag - GuruFocus

May 21, 2025

BioHarvest enters fragrance market with new AI-assisted project - Investing.com Australia

May 21, 2025

BioHarvest Expands into Fragrance Market with New CDMO Contract - TipRanks

May 21, 2025

BioHarvest inks fragrance compound deal in move into multi-billion-dollar scents market - Proactive financial news

May 21, 2025

Q4 EPS Estimate for BioHarvest Sciences Decreased by Analyst - Defense World

May 21, 2025

May 19, 2025

BioHarvest Sciences: Investors Remain Unconvinced Post Q1 Earnings Release - Seeking Alpha

May 19, 2025

May 17, 2025

BioHarvest Sciences advances CDMO deal with major pharmaceutical companyICYMI - Proactive Investors

May 17, 2025

BioHarvest outlines path to $11M–$12M quarterly revenue for adjusted EBITDA breakeven while expanding VINIA portfolio and CDMO pipeline - MSN

May 17, 2025

May 16, 2025